Skip to content

Clinical trials

Phase 2/3 trials in the Democratic Republic of the Congo

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Democratic Republic of the Congo Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20143
20151
20161
20181
20201
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Drugs for Neglected Diseases6
Jean-Pierre Van geertruyden1
Medicines for Malaria Venture1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novartis Pharmaceuticals1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Trypanosomiasis, African4
Malaria, Falciparum3
Hemorrhagic Fevers, Viral2
Infections2
Malaria2
Hemorrhagic Fever, Ebola1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.